Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections

Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections

Bibliographic Details
Main Authors:	Neoh, Hui-min, Hori, Satoshi, Komatsu, Mitsutaka, Oguri, Toyoko, Takeuchi, Fumihiko, Cui, Longzhu, Hiramatsu, Keiichi
Format:	Online
Language:	English
Published:	BioMed Central 2007
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2148052/

Similar Items

Reduced vancomycin susceptibility in porcine ST9 MRSA isolates
by: Kwok, Gabriella M. L., et al.
Published: (2013)

Vancomycin resistance among MRSA
by: Kumar, V. Anil
Published: (2012)

Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus
by: Katayama, Yuki, et al.
Published: (2016)

Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone
by: Graber, Christopher J., et al.
Published: (2007)

Acute MRSA Sinusitis with Intracranial Extension and Marginal Vancomycin Susceptibility
by: Kumar, Parvathi S., et al.
Published: (2013)

Reduced Susceptibility to Vancomycin in Staphylococcus aureus
by: Mimica, Marcelo J.
Published: (2011)

Difference in agr Dysfunction and Reduced Vancomycin Susceptibility between MRSA Bacteremia Involving SCCmec Types IV/IVa and I–III
by: Jang, Hee-Chang, et al.
Published: (2012)

Mluti-faceted interventions to prevent bloodstream MRSA infections
by: Orsman, PJ, et al.
Published: (2011)

An effective active surveillance method for controlling nosocomial MRSA transmission in a Japanese hospital
by: Ohkushi, Daisuke, et al.
Published: (2013)

Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings
by: SPAGNOLO, A.M., et al.
Published: (2014)

Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus
by: Rishishwar, Lavanya, et al.
Published: (2016)

Intestinal carriage of methicillin-resistant Staphylococcus aureus in nasal MRSA carriers hospitalized in the neonatal intensive care unit
by: Nakao, Akihiro, et al.
Published: (2014)

Increase in Bloodstream Infection Due to Vancomycin-Susceptible Enterococcus faecium in Cancer Patients: Risk Factors, Molecular Epidemiology and Outcomes
by: Gudiol, Carlota, et al.
Published: (2013)

In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey
by: Tekin, Alicem, et al.
Published: (2014)

Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis
by: Ishii, Kenichi, et al.
Published: (2015)

Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
by: Wang, Jiun-Ling, et al.
Published: (2004)

Evaluating vancomycin susceptibility in Staphylococcus aureus
by: Mimica, Marcelo J, et al.
Published: (2016)

Virulence factors in vancomycin-resistant and vancomycin- susceptible Enterococcus faecalis from Brazil
by: Camargo, I. L. B. C., et al.
Published: (2008)

Complete Genome Sequence of Vancomycin-Intermediate Staphylococcus aureus Strain MI (HIP5827)
by: Hishinuma, Tomomi, et al.
Published: (2016)

A targeted methicillin-resistant Staphylococcus aureus (MRSA) control program did not affect total nosocomial Staphylococcus aureus (SA) bloodstream infections (BSI) despite reducing MRSA BSI
by: Amri, B, et al.
Published: (2011)

Daptomycin susceptibility of methicillin resistant Staphylococcus aureus (MRSA)
by: Kaur, Rajneet, et al.
Published: (2012)

Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
by: Perazzi, Beatriz, et al.
Published: (2011)

Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
by: Perazzi, Beatriz, et al.
Published: (2011)

Reduced Vancomycin Susceptibility Found in Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Isolates in Northeast China
by: Hu, Jian, et al.
Published: (2013)

Global Association between Thermophilicity and Vancomycin Susceptibility in Bacteria
by: Roy, Chayan, et al.
Published: (2016)

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
by: Panesso, Diana, et al.
Published: (2015)

Phenotypic Characteristics of Vancomycin-Non-Susceptible Staphylococcus aureus
by: Sirichoat, Auttawit, et al.
Published: (2016)

Production of an Attenuated Phenol-Soluble Modulin Variant Unique to the MRSA Clonal Complex 30 Increases Severity of Bloodstream Infection
by: Cheung, Gordon Y. C., et al.
Published: (2014)

Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study
by: Dmitriy M. Martirosov, et al.
Published: (2017-08-01)

Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study
by: Cho, Sung-Yeon, et al.
Published: (2013)

Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching Hospital
by: da Costa, Thaina Miranda, et al.
Published: (2016)

Disposition of linezolid or daptomycin in Enterococcal bloodstream infections according to vancomycin resistant Enterococcus colonization
by: Short, Elizabeth, et al.
Published: (2014)

High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus
by: San-Juan, Rafael, et al.
Published: (2016)

Reducing preventable harm: observations on minimizing bloodstream infections
by: Peter J., Pronovost, et al.
Published: (2017)

Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy
by: Pletz, Mathias W, et al.
Published: (2010)

Pharmacodynamic Interaction of Quercus infectoria Galls Extract in Combination with Vancomycin against MRSA Using Microdilution Checkerboard and Time-Kill Assay
by: Basri, Dayang Fredalina, et al.
Published: (2012)

The Efficacy and Safety of Arbekacin and Vancomycin for the Treatment in Skin and Soft Tissue MRSA Infection: Preliminary Study
by: Hwang, Ji-Hee, et al.
Published: (2013)

Teicoplanin as an Effective Alternative to Vancomycin for Treatment of MRSA Infection in Chinese Population: A Meta-analysis of Randomized Controlled Trials
by: Peng, Yang, et al.
Published: (2013)

Evaluation of the Combined Effects of Stilbenoid from Shorea gibbosa and Vancomycin against Methicillin-Resistant Staphylococcus aureus (MRSA)
by: Basri, Dayang Fredalina, et al.
Published: (2012)

Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review
by: Shenoy, Erica S, et al.
Published: (2014)